As of May 3 2023, all stock of original/ancestral strain of Spikevax (Moderna) specific for children aged 6 months to 5 years has expired. Any remaining stock should not be administered and should be disposed of according to your state or territory’s requirements.
We have updated our guidelines to provide recommendations for children who have commenced their primary course with 1 dose of Spikevax and require further doses to complete their course.
- Immune competent children can complete their primary course with 1 dose of age-appropriate Comirnaty (Pfizer) only.
- Severely immunocompromised children who received 1 dose of Spikevax should receive a further 2 doses of Comirnaty 8 weeks apart to complete their primary course.
- Severely immunocompromised children who received 2 doses of Spikevax should receive 1 further dose of Comirnaty 8 weeks later to complete their primary course.
Please note, vaccination is only recommended in this age group for children with severe immunocompromise, disability or a complex medical condition that places them at a higher risk of severe COVID-19 disease.
Find complete recommendations for children aged 6 months to 5 years on MVEC: COVID-19 vaccination in children and adolescents.